Suchergebnisse - "Becherer, A"

PubPharm (4)

1

Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial

enthalten in: Journal of surgical oncology | 2015

von Vrachimis, A. | Wenning, C. | Gerß, J. | +105

2

Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth : results of the MSDS trial

enthalten in: European journal of endocrinology | 2010

von Krämer, J. | Schmid, K. | Dralle, H. | +108

3

Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial

enthalten in: Nuklearmedizin. Nuclear medicine | 2009

von Biermann, M. | Pixberg, M. | Riemann, B. | +107

4

Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 1996

von Raderer, M. | Becherer, A. | Kurtaran, A. | +8

1
[1]